Apo-Semaglutide Injection : Incorrect dose display
Brand(s)
Last updated
Summary
Product
Apo-Semaglutide
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|
|---|---|---|---|---|---|---|
Apotex Inc. |
Apo-Semaglutide (2 mg/pen) |
DIN 02568020 |
Solution |
Semaglutide 0.68 mg/ml |
700059A |
Issue
The affected lot may display a 2 mg dose in the dose window and deliver a 2 mg dose instead of the expected 0.25 mg or 0.5 mg dose.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Retaillers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Apotex Inc.
150 Signet Drive,
Toronto, ON, M9L 1T9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-82536
Get notified
Receive emails about new and updated recall and safety alerts.